BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9920854)

  • 1. Antineoplastic urinary protein inhibits Kaposi's sarcoma and angiogenesis in vitro and in vivo.
    Masood R; McGarvey ME; Zheng T; Cai J; Arora N; Smith DL; Sloane N; Gill PS
    Blood; 1999 Feb; 93(3):1038-44. PubMed ID: 9920854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
    Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
    J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
    Sgadari C; Barillari G; Toschi E; Carlei D; Bacigalupo I; Baccarini S; Palladino C; Leone P; Bugarini R; Malavasi L; Cafaro A; Falchi M; Valdembri D; Rezza G; Bussolino F; Monini P; Ensoli B
    Nat Med; 2002 Mar; 8(3):225-32. PubMed ID: 11875492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist.
    Masood R; Nagpal S; Zheng T; Cai J; Tulpule A; Smith DL; Gill PS
    Blood; 2000 Nov; 96(9):3188-94. PubMed ID: 11050002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
    Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
    Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
    Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B
    J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
    Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
    J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin.
    Samaniego F; Bryant JL; Liu N; Karp JE; Sabichi AL; Thierry A; Lunardi-Iskandar Y; Gallo RC
    J Natl Cancer Inst; 1999 Jan; 91(2):135-43. PubMed ID: 9923854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Kaposi's sarcoma in vivo by fenretinide.
    Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human chorionic gonadotropin inhibits Kaposi's sarcoma associated angiogenesis, matrix metalloprotease activity, and tumor growth.
    Pfeffer U; Bisacchi D; Morini M; Benelli R; Minghelli S; Vacca A; Noonan DM; Albini A
    Endocrinology; 2002 Aug; 143(8):3114-21. PubMed ID: 12130577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi's sarcoma.
    Arastéh K; Hannah A
    Oncologist; 2000; 5 Suppl 1():28-31. PubMed ID: 10804088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells.
    Marchiò S; Primo L; Pagano M; Palestro G; Albini A; Veikkola T; Cascone I; Alitalo K; Bussolino F
    J Biol Chem; 1999 Sep; 274(39):27617-22. PubMed ID: 10488101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of Kaposi's sarcoma cell growth by urine from women in early pregnancy, the current source for clinical-grade human chorionic gonadotropin preparations.
    Simonart T; Hermans P; Delogne-Desnoeck J; Van Vooren JP; Meuris S
    Exp Dermatol; 2002 Aug; 11(4):365-9. PubMed ID: 12190946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
    Ensoli B; Markham P; Kao V; Barillari G; Fiorelli V; Gendelman R; Raffeld M; Zon G; Gallo RC
    J Clin Invest; 1994 Nov; 94(5):1736-46. PubMed ID: 7525646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.
    Masood R; Cai J; Zheng T; Smith DL; Naidu Y; Gill PS
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):979-84. PubMed ID: 9023368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line.
    Albini A; Paglieri I; Orengo G; Carlone S; Aluigi MG; DeMarchi R; Matteucci C; Mantovani A; Carozzi F; Donini S; Benelli R
    AIDS; 1997 May; 11(6):713-21. PubMed ID: 9143602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.
    Bussolino F; Arese M; Montrucchio G; Barra L; Primo L; Benelli R; Sanavio F; Aglietta M; Ghigo D; Rola-Pleszczynski MR
    J Clin Invest; 1995 Aug; 96(2):940-52. PubMed ID: 7543496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells.
    Arora N; Masood R; Zheng T; Cai J; Smith DL; Gill PS
    Cancer Res; 1999 Jan; 59(1):183-8. PubMed ID: 9892205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical pro-Kaposi's sarcoma activity of preparations of human chorionic gonadotropin.
    Simonart T; Hermans P; Van Vooren JP; Meuris S
    Blood; 1999 Jul; 94(1):376-7. PubMed ID: 10428550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.